Abbott's RELIEF study shows FreeStyle Libre system reduces diabetes─related hospitalizations for people with type 2 diabetes on once─daily insulin therapy

Abbott announced new data from the Real World Evidence of FreeStyle Libre (RELIEF) study showing the use of FreeStyle Libre, a continuous glucose monitoring system (CGM) significantly reduced the rate of